Exoskeleton trial programmes in Europe:
what to expect

Why trials are so frequently requested — and so often unresolved

The exoskeleton purchase decision is genuinely difficult. Devices cost €2,000–10,000 per unit. Fleet deployments run to five- and six-figure sums. The technology is still relatively unfamiliar to most operations teams, and vendor claims are difficult to verify without operational experience. It is entirely rational for buyers to want to test before committing.

The problem is structural. Vendors incur significant cost to support a trial — logistics, on-site visits, training, equipment risk. Many decline outright. Those that do offer trials often provide short demo periods (days rather than weeks) that are insufficient to produce reliable conclusions. And because the trial is open-ended, it frequently produces no outcome at all — the devices go back, and the decision stalls.

The three types of trial arrangements in the European market

Most buyers are not aware that there are meaningfully different types of trial arrangement, each with different implications for cost, commitment, and risk.

What a paid rental actually costs

Paid rental is the most common trial structure offered by European vendors today. The economics, however, are rarely presented clearly to buyers at the start.

At €400–500 per unit per week, a four-week trial of two units costs €3,200–4,000 — with no path to purchase. If the trial extends to eight weeks (which frequently happens when success criteria are not pre-defined), the cost doubles. And if the result is positive, the buyer then pays the full purchase price on top — meaning they have spent €3,000–8,000 evaluating a device before paying €6,000–20,000 to actually buy it.

What Deploy & Decide changes

The Deploy & Decide model inverts the trial economics. The buyer pays the full purchase price upfront — typically for one or two units — and receives a defined evaluation window (four or eight weeks). If the deployment succeeds, the purchase is complete: no further action, no additional invoicing. If the deployment fails — the device doesn't fit the task, workers won't adopt it, or the operational constraints can't be resolved — the buyer returns the units and receives a partial refund.

The buyer's maximum evaluation cost is known before the trial begins. The trial has a clear end date. And the vendor — unlike in a free loan — has a financial stake in the outcome, which means genuine support during the evaluation period rather than a drop-off and check-in six weeks later.

For operations teams, the practical implication is significant: the decision timeline is defined, the financial exposure is capped, and the evaluation produces a result — one way or the other.

What to negotiate before any trial begins

Regardless of which trial structure is available, the following terms should be agreed in writing before any units arrive on site:

• Duration. Four weeks is the minimum for a reliable assessment. Eight weeks is appropriate for complex deployments or multi-shift environments. Agree the end date upfront — do not leave it open.
• Number of units. Two units across different workers is the minimum for a meaningful comparison. One unit evaluated by one worker does not produce conclusions that generalise across a team.
• Support commitment. What does the vendor provide during the trial? On-site fitting, check-in visits, remote support for worker feedback collection? Agree this before units arrive.
• Success criteria. What does a positive outcome look like? Worker comfort scores after two weeks? Fatigue rating improvement? Absence of reported movement restriction? Define this before the trial — not after.
• Return conditions. If the trial fails, what condition must units be returned in? Are there inspection fees or damage charges that are not disclosed upfront?
• Purchase path. If the trial succeeds, what are the pricing and delivery terms for the fleet order? Agree indicative fleet pricing before the trial — not after a successful evaluation when your negotiating position is weakest.

The independent selection question

The trial structure matters — but it matters less than device selection. A four-week structured trial of the wrong device still produces a failed deployment. The selection step — identifying which devices are genuinely compatible with your task, environment, and workforce — should happen before any trial arrangement is made.

Most European buyers still enter the trial process via a vendor-initiated contact: a cold call, a trade fair conversation, or a referral from another operation. That means the device being trialled is the one the vendor is most motivated to sell — not necessarily the one best suited to the task. An independent selection process changes that starting point entirely.